Dual-Defense Functionality of Temporin-1LS From Dark-Spotted Frogs: Antimicrobial Activity and I

10 Apr 20264 min read0 viewsJournal Feed

GIST

IntroductionThe escalating crisis of antibiotic resistance highlights the urgent need for novel antimicrobial agents. This study aims to identify and characterize temporin-1LS, a temporin-family antimicrobial peptide from the dark-spotted frog (Pelophylax nigromaculatus), and to investigate its biological functions, including antimicrobial and immunomodulatory activities.

MethodsStructural and phylogenetic analyses were conducted to determine the peptide’s conformation and evolutionary relationship. Expression levels of temporin-1LS in various tissues were assessed under basal and pathogen-challenged conditions using Aeromonas hydrophila.

The antimicrobial activity of synthetic temporin-1LS was evaluated by determining minimum inhibitory concentrations (MICs) against bacterial strains. Immunomodulatory functions, including macrophage chemotaxis, phagocytosis, and respiratory burst, were examined in vitro.

ResultTemporin-1LS possesses a conserved amphipathic α-helical structure and shows high phylogenetic homology with temporin-1GY. It was constitutively highly expressed in frog skin and significantly upregulated in the gut (47.4-fold) and liver (24.3-fold) following A.

hydrophila challenge. The synthetic peptide exhibited potent and selective antibacterial activity against Staphylococcus warneri and Vibrio alginolyticus (MIC = 3.125 µg/mL).

Clinical Editorial

The study objective and scope

The research investigates temporin-1LS, a temporin-family antimicrobial peptide from the dark-spotted frog (Pelophylax nigromaculatus), focusing on its antimicrobial and immunomodulatory activities.

Study design and methods

Structural and phylogenetic analyses were conducted to characterize conformation and evolutionary relationships.
Tissue expression profiles were measured under baseline conditions and after pathogen challenge with Aeromonas hydrophila.
Antimicrobial activity was assessed using synthetic temporin-1LS to determine minimum inhibitory concentrations (MICs) against bacterial strains.
Immunomodulatory functions were explored in vitro via macrophage chemotaxis, phagocytosis, and respiratory burst assays.

Key findings on structure, expression, and antimicrobial activity

hydrophila exposure in the gut (approximately 47.4-fold) and liver (about 24.3-fold).

hydrophila but improved survival in a frog infection model when administered.

Temporin-1LS has a conserved amphipathic α-helical structure and shows high phylogenetic similarity to temporin-1GY.
Baseline expression is high in frog skin, with marked upregulation after A.
The synthetic peptide demonstrated potent and selective antibacterial activity against Staphylococcus warneri and Vibrio alginolyticus, with an MIC reported as 3.125 µg/mL.
Higher concentrations (50–100 µg/mL) increased bacterial LDH release relative to a BSA control, indicating potential membrane disruption at those doses.
Notably, temporin-1LS did not exhibit measurable in vitro activity against A.

Immunomodulatory effects and functional implications

The peptide markedly modulated macrophage activity in a dose-dependent manner: chemotaxis increased approximately 2.4-fold, phagocytosis rose by about 4.4-fold, and respiratory burst amplified roughly 1.6-fold.
These effects suggest an immunomodulatory role that complements direct antimicrobial actions.

Context, limitations, and practical relevance

hydrophila and the need for broader infection models to generalize findings.

The dual-defense model combines direct antimicrobial activity against select pathogens with enhancement of macrophage functions to aid infection resolution.
Limitations include differential in vitro activity versus in vivo efficacy against A.
The authors position temporin-1LS as a scaffold for developing immunomodulatory anti-infectives.